Image source: Shutterstock

Highlights

  • Healius shares tumble 30% in early trade after going ex-dividend for a special payout.

  • The dividend stems from the $822 million cash sale of Lumus Imaging.

  • Despite the drop, the move is not linked to negative business performance or outlook.

Healius Ltd (ASX:HLS) shares are experiencing a sharp sell-off today, plunging 30% to a 52-week low of $1.07 in morning trade, as the stock goes ex-dividend for a special payout. 

In contrast, this decline is tied to a technical market event — Healius shares are trading ex-dividend following the company’s announcement earlier this week of a special dividend, made possible by the completion of a significant asset sale.

The healthcare company recently finalised the sale of Lumus Imaging to funds managed by Affinity Equity Partners, generating cash proceeds of $822 million. After accounting for the repayment of equipment leases and closing adjustments, the transaction reflects an enterprise value of $965 million. Net proceeds are expected to exceed $800 million after transaction and separation costs.

The substantial capital return is what prompted the special dividend and, as a result, today's market activity.

When a stock goes ex-dividend, it means that new buyers will no longer be eligible to receive the upcoming dividend payment. That right remains with the seller, even though they’ve sold the shares. In most cases, the share price will decline by roughly the value of the dividend to reflect this, which explains the sharp drop in Healius shares this morning.

Importantly, the drop in share price is not due to a negative trading update, financial downgrade, or operational setback. 

Despite the volatility, the broader S&P/ASX 200 Index (ASX: XJO) was trading 0.15% higher at the same time, highlighting the Healius-specific nature of the move.